Hitomi Sumiyoshi Okuma, Hiroshi Yoshida, Yoshihisa Kobayashi, Motoko Arakaki, Chiharu Mizoguchi, Lina Inagaki, Pei Jye Voon, Adam Malik Bin Ismail, Hwoei Fen Soo Hoo, Suhana Yusak, et al. Molecular pathology quality control in Southeast Asia: Results of a multiregional quality assurance study from MASTER KEY Asia. Cancer science. 2023. 114. 6. 2664-2673
Yoshihisa Kobayashi, Geoffrey R. Oxnard, Elizabeth F. Cohen, Navin R. Mahadevan, Joao V. Alessi, Yin P. Hung, Arrien A. Bertram, David E. Heppner, Mauricio F. Ribeiro, Karina P. Sacardo, et al. Genomic and biological study of fusion genes as resistance mechanisms to EGFR inhibitors. Nature Communications. 2022
Ryohei Yoshida, Maria Saigi, Tetsuo Tani, Benjamin F Springer, Hirofumi Shibata, Shunsuke Kitajima, Navin R Mahadevan, Marco Campisi, William Kim, Yoshihisa Kobayashi, et al. MET-induced CD73 restrains STING-mediated immunogenicity of EGFR-mutant lung cancer. Cancer research. 2022. 82. 21. 4079-4092
Masahiro Higashiyama, Yoshihisa Kobayashi, Jumpei Kashima, Yuji Muraoka, Hirokazu Watanabe, Masahiko Kusumoto, Shun-Ichi Watanabe, Yasushi Yatabe. Invasive Mucinous Adenocarcinoma of the Lung with a Mural Nodule-like Lesion. The American journal of surgical pathology. 2022
Ciric To, Tyler S Beyett, Jaebong Jang, William W Feng, Magda Bahcall, Heidi M Haikala, Bo H Shin, David E Heppner, Jaimin K Rana, Brittaney A Leeper, et al. An allosteric inhibitor against the therapy-resistant mutant forms of EGFR in non-small cell lung cancer. Nature cancer. 2022
